LIPLASOME PHARMA
LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin -> LiPlaCis®, Oxaliplatin -> LiPloxa. The aim is to provide more effective treatment to cancer patients with fewer side effects.
LIPLASOME PHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2002-01-01
Address:
Vejle, Syddanmark, Denmark
Country:
Denmark
Website Url:
http://www.liplasome.com
Total Employee:
11+
Status:
Active
Contact:
45 88 70 80 20
Total Funding:
8.01 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Sectigo SSL Sectigo Domain SSL LiteSpeed
Similar Organizations
Investors List
Incuba Venture
Incuba Venture investment in Series B - LiPlasome Pharma
BankInvest Biomedical Venture
BankInvest Biomedical Venture investment in Series B - LiPlasome Pharma
Vecata
Vecata investment in Series B - LiPlasome Pharma
Official Site Inspections
http://www.liplasome.com
- Host name: linux7.curanet.dk
- IP address: 185.21.40.99
- Location: Denmark
- Latitude: 55.7123
- Longitude: 12.0564
- Timezone: Europe/Copenhagen
Loading ... 